Search Results - "Cairoli, R."

Dual antiviral therapy in haematological patients with protracted SARS‐CoV‐2 infection by Peracchi, F., Merli, M., Rogati, C., Ravano, E., Puoti, M., Cairoli, R., Travi, G.

Get full text

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia by Alfonso, V., Iaccarino, L., Ottone, T., Cicconi, L., Lavorgna, S., Divona, M., Cairoli, R., Cristiano, A., Ciardi, C., Travaglini, S., Falconi, G., Hasan, S. K., Venditti, A., Arcese, W., Voso, M. T., Lo-Coco, F.

Get full text

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study by Cairoli, Roberto, Beghini, Alessandro, Grillo, Giovanni, Nadali, Gianpaolo, Elice, Francesca, Ripamonti, Carla Barbara, Colapietro, Patrizia, Nichelatti, Michele, Pezzetti, Laura, Lunghi, Monia, Cuneo, Antonio, Viola, Assunta, Ferrara, Felicetto, Lazzarino, Mario, Rodeghiero, Francesco, Pizzolo, Giovanni, Larizza, Lidia, Morra, Enrica

“…Distinct forms of tyrosine kinase domain (TKD), juxtamembrane domain, exon 8, and internal tandem duplication (ITD) mutations of c-KIT, were observed in about…”
Get full text

A Proposal of Multi-Dimensional Evaluation of Elderly Patients Affected by MDS: The “No-Chain” Algorithm by Riva, M, Ravano, E, Cairoli, R, Molteni, A

Get full text

EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME by Frustaci, A. M., Montillo, M., Rossi, D., Zinzani, P. L., Motta, M., Gaidano, G., Quaresmini, G., Scarfò, L., Pietrasanta, D., Coscia, M., Deodato, M., Zamprogna, G., Cairoli, R., Stüssi, G., Zucca, E., Pileri, S., Zenz, T., Tedeschi, A.

Get full text

GRANISETRON TRANSDERMAL DELIVERY SYSTEM USE IN LYMPHOPROLIFERATIVE DISEASE: A SINGLE CENTER EXPERIENCE by Minga, P., Muzi, C., Zilioli, V., Meli, E., Rusconi, C., Deodato, M., Cairoli, R.

Get full text

MOLTO, A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CLINICAL TRIAL ON VENETOCLAX, ATEZOLIZUMAB, OBINUTUZUMAB IN RICHTER TRANSFORMATION: SAFETY INTERIM ANALYSIS by Frustaci, A. M., Tedeschi, A., Zinzani, P. L., Pietrasanta, D., Coscia, M., Zenz, T., Motta, M., Gaidano, G., Scarfò, L., Deodato, M., Zamprogna, G., Vitale, C., Cairoli, R., Rossi, D., Montillo, M.

Get full text

A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis by Cristallo, A. F., Schroeder, J., Citterio, A., Santori, G., Ferrioli, G. M., Rossi, U., Bertani, G., Cassano, S., Gottardi, P., Ceschini, N., Barocci, F., Ribizzi, G., Cutrupi, V., Cairoli, R., Rapisarda, V., Pastorello, E. A., Barocci, S.

“…Summary Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are represented by rare but life‐threatening cutaneous adverse reactions to…”
Get full text

RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia by BEGHINI, Alessandro, RIPAMONTI, Carla B, PETERLONGO, Paolo, ROVERSI, Gaia, CAIROLI, Roberto, MORRA, Enrica, LARIZZA, Lidia

“…The SH2 domain-containing tyrosine phosphatase PTPN6 (SHP-1, PTP1C, HCP) is a 68 kDa cytoplasmic protein primarily expressed in hematopoietic cell development,…”
Get full text

C-kit mutations in core binding factor leukemias by Beghini, A, Peterlongo, P, Ripamonti, C B, Larizza, L, Cairoli, R, Morra, E, Mecucci, C

Get full text

P517: PROSPECTIVE MULTICENTRIC STUDY ON INFECTIOUS COMPLICATIONS AND CLINICAL OUTCOME IN 230 UNFIT AML PATIENTS TREATED IN FIRST‐LINE WITH HYPOMETHYLATING AGENTS ALONE OR IN COMBINATION WITH VENETOCLAX by Candoni, A., Piccini, M., Lazzarotto, D., Bonuomo, V., Dargenio, M., Riva, M., Mellillo, L., Papayannidis, C., Stulle, M., Dragonetti, G., Del Principe, M. I., Cattaneo, C., Pasciolla, C., De Marchi, R., Delia, M., Tisi, M. C., Zannier, M. E., Nadali, G., Sciumè, M., Spadea, A., Sartor, C., Griguolo, D., Buzzatti, E., Basilico, C. M., Sarlo, C., Piccioni, A. L., Cairoli, R., Olivieri, A., Pagano, L.

Get full text

Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia by NOSARI, A, RAVINI, M, CAIROLI, R, COZZI, P, MARBELLO, L, MARENCO, P, GRILLO, G, MORRA, E

“…Antifungal therapy may be unable to eradicate invasive mycosis in leukemia patients. The presence of persisting pulmonary nodules owing to mycosis seems to…”
Get full text

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma by Arcaini, L., Montanari, F., Alessandrino, E.P., Tucci, A., Brusamolino, E., Gargantini, L., Cairoli, R., Bernasconi, P., Passamonti, F., Bonfichi, M., Zoli, V., Bottelli, C., Calatroni, S., Troletti, D., Merli, M., Pascutto, C., Majolino, I., Rossi, G., Morra, E., Lazzarino, M.

“…To evaluate the clinical outcome of patients with relapsed or refractory follicular lymphoma treated with immunochemotherapy, in vivo purging and high-dose…”
Get full text

Safety of recreational scuba diving in type 1 diabetic patients: The Deep Monitoring programme by Bonomo, M, Cairoli, R, Verde, G, Morelli, L, Moreo, A, Grottaglie, M. Delle, Brambilla, M.C, Meneghini, E, Aghemo, P, Corigliano, G, Marroni, A

“…Abstract Aim To verify whether, with thorough practical and theoretical training, well-controlled, non-complicated diabetic patients can safely go diving…”
Get full text

c-kit Activating Mutations and Mast Cell Proliferation in Human Leukemia by Beghini, A., Larizza, L., Cairoli, R., Morra, E.

Get full text

Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens by NOSARI, A, CAIROLI, R, MORRA, E, CIAPANNA, D, GARGANTINI, L, INTROPIDO, L, BARATE, C, SCARPATI, B, SANTOLERI, L, NADOR, G, PEZZETTI, L

“…Systematic data on the ability of pegfilgrastim to mobilize stem cells after chemotherapy are scarce. We evaluated the efficacy of a single 6 mg dose of…”
Get full text

C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index by Cairoli, R, Grillo, G, Beghini, A, Tedeschi, A, Ripamonti, C B, Larizza, L, Morra, E

“…LEUKEMIA: (2003) 17, 471-472. doi:10.1038/sj.leu.2402795…”
Get full text

A sequence of immuno‐chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high‐dose chemotherapy and autotransplant is an effective 
and non‐toxic treatment for advanced follicular 
and mantle cell lymphoma by Lazzarino, M., Arcaini, L., Bernasconi, P., Alessandrino, E. P., Gargantini, L., Cairoli, R., Orlandi, E., Astori, C., Brusamolino, E., Pagnucco, G., Colombo, A. A., Calatroni, S., Iacona, I., Regazzi, M. B., Morra, E.

“…Options for relapsed/refractory indolent lymphoma include chemotherapy, immunotherapy and high‐dose therapy with autologous support. The best combination of…”
Get full text

Answer from authors about the article “Safety of recreational scuba diving in type 1 diabetic patients: The Deep Monitoring programme” by Bonomo, M, Cairoli, R, Verde, G, Morelli, L, Moreo, A, Delle Grottaglie, M, Brambilla, M.C, Meneghini, E, Aghemo, P, Corigliano, G, Marroni, A

Get full text

Dual antiviral therapy in haematological patients with protracted SARS‐C o V ‐2 infection by Peracchi, F., Merli, M., Rogati, C., Ravano, E., Puoti, M., Cairoli, R., Travi, G.

Get full text